Solana trades at $89.05 with neutral RSI signaling potential bounce. Technical analysis suggests $95 resistance test possible, but $85 support remains critical. (Solana trades at $89.05 with neutral RSI signaling potential bounce. Technical analysis suggests $95 resistance test possible, but $85 support remains critical. (

SOL Price Prediction: Solana Eyes $95 Breakout Despite Current Consolidation

2026/03/26 15:52
4 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

SOL Price Prediction: Solana Eyes $95 Breakout Despite Current Consolidation

Caroline Bishop Mar 26, 2026 07:52

Solana trades at $89.05 with neutral RSI signaling potential bounce. Technical analysis suggests $95 resistance test possible, but $85 support remains critical.

SOL Price Prediction: Solana Eyes $95 Breakout Despite Current Consolidation

SOL Price Prediction Summary

Short-term target (1 week): $92-95 • Medium-term forecast (1 month): $85-$105 range
Bullish breakout level: $95.73 (Upper Bollinger Band) • Critical support: $85.78

What Crypto Analysts Are Saying About Solana

While specific analyst predictions are limited for the current timeframe, on-chain metrics suggest Solana remains in a consolidation phase. According to technical data analysis, SOL's neutral RSI positioning at 49.66 indicates the asset is neither overbought nor oversold, creating potential for directional movement in either direction.

Market data platforms show Solana maintaining strong trading volumes of $247 million over 24 hours on Binance alone, indicating sustained institutional and retail interest despite the recent 3.13% decline.

SOL Technical Analysis Breakdown

The current SOL price prediction relies heavily on key technical indicators showing mixed signals. Solana's RSI at 49.66 sits firmly in neutral territory, suggesting the recent selling pressure may be exhausting without indicating immediate bullish momentum.

The MACD histogram reading of 0.0000 presents a concerning bearish momentum signal, though this could indicate Solana is approaching a potential trend reversal point. With the MACD line at 0.4641 matching the signal line, SOL appears to be at a critical decision point.

Solana's Bollinger Bands analysis reveals the price trading at 52.51% of the band range, positioning SOL closer to the middle band ($88.70) than either extreme. This suggests room for movement in both directions, with the upper band at $95.73 representing immediate resistance and the lower band at $81.67 providing downside support.

The moving average structure shows mixed signals for this Solana forecast. While SOL trades above the 20-day SMA ($88.70) and 50-day SMA ($86.14), it remains significantly below the 200-day SMA at $143.26, indicating the longer-term trend remains bearish.

Solana Price Targets: Bull vs Bear Case

Bullish Scenario

The optimistic SOL price prediction targets the $95.10 strong resistance level, representing a 6.8% upside from current levels. A successful break above this level could propel Solana toward the upper Bollinger Band at $95.73.

Technical confirmation would require RSI breaking above 55 and MACD histogram turning positive. The immediate resistance at $92.08 serves as the first hurdle, with volume expansion above 300 million daily needed to sustain upward momentum.

If bulls regain control, Solana could test the psychological $100 level within the month, though this would require broader crypto market support and specific positive catalysts for the Solana ecosystem.

Bearish Scenario

The pessimistic Solana forecast sees immediate support at $87.42 being tested if selling pressure continues. A break below this level could trigger stops and push SOL toward the strong support at $85.78.

The most concerning scenario involves a breakdown below the lower Bollinger Band at $81.67, which could initiate a deeper correction toward the $75-80 range. The MACD's current bearish momentum supports this downside risk.

Risk factors include broader crypto market weakness, regulatory concerns, or network-specific issues that could pressure Solana below critical support levels.

Should You Buy SOL? Entry Strategy

For this SOL price prediction scenario, strategic entry points emerge at current levels around $89 for risk-tolerant traders, with a stop-loss below $85.78 to limit downside exposure.

Conservative investors might wait for a clear break above $92.08 with volume confirmation before establishing positions. The risk-reward ratio appears favorable with resistance targets offering 6-7% upside against 4% downside to strong support.

Position sizing should account for Solana's daily ATR of $4.51, indicating significant intraday volatility. A 2-3% portfolio allocation represents prudent risk management given the current technical uncertainty.

Conclusion

This SOL price prediction suggests Solana stands at a critical juncture with potential for a 6-8% rally toward $95-97 if bulls can reclaim momentum. However, the neutral RSI and bearish MACD histogram warrant caution.

The most probable scenario sees SOL trading between $85-95 over the next month, with a breakout above $95 needed to invalidate bearish concerns. Traders should monitor volume patterns and broader market sentiment closely.

Disclaimer: Cryptocurrency price predictions involve significant risk. This analysis is for educational purposes and should not be considered financial advice. Always conduct your own research and consider your risk tolerance before making investment decisions.

Image source: Shutterstock
  • sol price analysis
  • sol price prediction
Market Opportunity
Solana Logo
Solana Price(SOL)
$87.67
$87.67$87.67
-4.46%
USD
Solana (SOL) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

The FDA Is Trying To Make Corporate Free Speech Situational

The FDA Is Trying To Make Corporate Free Speech Situational

The post The FDA Is Trying To Make Corporate Free Speech Situational appeared on BitcoinEthereumNews.com. BENSENVILLE, ILLINOIS – SEPTEMBER 10: Flanked by U.S. Attorney General Pam Bondi (rear), and FDA Commissioner Marty Makary (R), Secretary of Health and Human Services Robert F. Kennedy Jr. speaks to the press outside Midwest Distribution after it was raided by federal agents on September 10, 2025 in Bensenville, Illinois. According to the company, various e-liquids were seized in the raid. (Photo by Scott Olson/Getty Images) Getty Images While running for President in 2008, Barack Obama famously chanted “Yes we can.” Love or hate his political views, Obama’s politics were quite effective. He was asking voters to think big, to envision a much better future. Advertisers no doubt approved. That’s because ads routinely evoke things not as they are, but as they could be. Gyms and exercise equipment companies don’t promote their locations and equipment with flabby, lumbering people, rather their ads show fit, upright, energetic individuals. A look ahead. Restaurants do the same with ads showing happy people enjoying impressively put together plates of food. Conversely, ads meant to convince smokers to quit have not infrequently shown the worst of the worst future downsides of the habit. The nature of advertising comes to mind as FDA commissioner Marty Makary puzzlingly brags that “The Trump Administration Is Taking On Big Pharma” in the New York Times. Makary laments pharmaceutical ads that “are filled with dancing patients, glowing smiles and catch jingles that drown out the fine print.” Not explained is whether Makary would be happier if drug companies placed ads with immobile patients, frowns, and funereal music. Seriously, what does he expect? Does he want drug companies to commit billions to drug development to accompany their achievements with imagery defined by misery? Has Makary stopped to contemplate the myriad shareholders lawsuits drugmakers would face if, upon risking staggering sums meant…
Share
BitcoinEthereumNews2025/09/18 06:29
Why Customers Are Choosing Digital Banks Over Traditional Banks

Why Customers Are Choosing Digital Banks Over Traditional Banks

A 2025 J.D. Power survey of 90,000 retail banking customers across 18 countries found that digital banks outperformed traditional banks on customer satisfaction
Share
Techbullion2026/03/26 17:58
USD/MXN: Critical 200-Day Moving Average Hurdle Threatens Peso’s Rebound – Societe Generale Analysis

USD/MXN: Critical 200-Day Moving Average Hurdle Threatens Peso’s Rebound – Societe Generale Analysis

BitcoinWorld USD/MXN: Critical 200-Day Moving Average Hurdle Threatens Peso’s Rebound – Societe Generale Analysis The Mexican peso’s recent recovery against the
Share
bitcoinworld2026/03/26 18:20